Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29

Archives of Internal Medicine

Volumn 159, Issue 10, 1999, Pages 1097-1103

  Davis, Timothy M E ^a   Millns, Helen ^b   Stratton, Irene M ^b   Holman, Rury R ^b   Turner, Robert C ^b   Bassett, Philip ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; STROKE;

ADULT; ATRIAL FIBRILLATION; BLOOD GLUCOSE; BODY MASS INDEX; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; GREAT BRITAIN; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 0033599964     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.10.1097     Document Type: Article

References (46)

1. Kannel WB, McGee DL. Diabetes and cardiovascular disease: the Framingham Study. JAMA. 1979;241:2035-2038.
2. Aronson SM. Intracranial vascular lesions in patients with diabetes mellitus. J Neuropathol Exp Neurol. 1973;23:183-196.
3. Biller J, Love BB. Diabetes and stroke. Med Clin North Am. 1993;77:95-110.
4. Hadden WC, Harris MI. Prevalence of diagnosed diabetes, undiagnosed diabetes, and impaired glucose tolerance in adults 20-74 years of age. Vital Health Stat 11. 1987;No. 237:1-55.
5. Barker WH, Feldt KS, Felbel JH. Community surveillance of strokes in persons under 70 years old. Am J Public Health. 1983;73:260-265.
6. Loug S, Melamed E, Cahane E, Carmen A. Hypertension and diabetes as risk factors in stroke patients. Stroke. 1973;4:751-759.
7. Kagan A, Popper JS, Rhoads GG. Factors related to stroke incidence in Hawaii in Japanese men. Stroke. 1980;11:14-21.
8. Stallones R, Dyken M, Fang HCH. Epidemiology for stroke facilities planning. Stroke, 1972;3:360-371.
9. Roehmodt ME, Palumbo PJ, Whisnant JP, Elusback LR. Transient ischemic attack and stroke in a community-based diabetic cohort. Mayo Clin Proc. 1983; 58:56-58.
10. Ostfeld AM, Shekelle RB, Kiawans H, Tufo HM. Epidemiology of stroke in an elderly welfare population. Am J Public Health. 1974;64:450-458.
11. Lindegard B, Hillbom M. Associations between brain infarction, diabetes and alcoholism: observations from the Gothenburg population cohort study. Acta Neurol Scand. 1987;75:195-200.
12. Kuller L, Anderson H, Peterson D. Nationwide cerebrovascular disease morbidity survey. Stroke. 1970;1:86-99.
13. Wolf PA, Kannel WB, Verter J. Current status of risk factors for stroke. Neurol Clin. 1983;1:317-343.
14. Herman B, Leyten ACM, van Luijk JH, Frenken CW, Op de Coul AA, Schulte BP. An evaluation of risk factors for stroke in a Dutch community. Stroke. 1982;13: 334-339.
15. Lackland DT, Moore MA. Hypertension-related mortality and morbidity in the Southeast. South Med J. 1997;90:191-198.
16. Bell DSH. Stroke in the diabetic patient. Diabetologia. 1994;17:213-219.
17. Sacco RL. Risk factors and outcomes for ischemie stroke. Neurology. 1995;45 (suppl 1):S10-S14.
18. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts: prospective studies collaboration. Lancet. 1995;346: 1647-1653.
19. Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano K. Diabetes and the risk factors of stroke: the Honolulu Heart Program. JAMA. 1987;257:949-952.
20. Palumbo PJ, Elveback LR, Whisnant JP. Neurological complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy. Adv Neurol. 1978;19:593-601.
21. Stegmayr B, Asplund K. Diabetes as a risk factor for stroke: a population perspective. Diabetologia. 1995;38:1061-1068.
22. Tunbridge WMG. Factors contributing to deaths of diabetics under fifty years of age: on behalf of the Medical Services Study Group and British Diabetic Association. Lancet. 1981;2:569-572.
23. Webster P. The natural history of stroke in diabetic patients. Acta Med Scand. 1980;207:417-424.
24. UKPDS Group. UK Prospective Diabetes Study, VIII: study design, progress, and performance. Diabetologia. 1991;34:877-890.
25. World Health Organization. International Classification of Diseases, Ninth Revision. Geneva, Switzerland: World Health Organization; 1977.
26. UKPDS Group. UK Prospective Diabetes Study, XI: biochemical risk factors in type 2 diabetic patients at diagnosis compared with age-matched normal subjects, Diabet Med. 1994;11:534-544.
27. Cox DR. Regression models and life-tables. J R Stat Soc Ser B. 1972;34:187-201.
28. Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med. 1991;10:1025-1035.
29. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
30. Hypertension in Diabetes Study Group. HDS 4: therapeutic requirements to maintain tight blood pressure control. Diabetologia. 1996;39:1554-1561.
31. Tuomilehto J, Rastenyte D, Lutgarde T, Staessen J. Reduction in mortality and cardiovascular events in older diabetic patients with isolated systolic hypertension in Europe treated with nitrendipine-based antihypertensive therapy (SystEur Trial) [abstract]. Diabetes. 1998;47:54A.
32. Hansson L, Zanchetti A, Carruthers SG, et al, for the HOT Study Group. Effects of blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351:1755-1762.
33. Cutler JA. Calcium-channel blockers for hypertension: uncertainty continues. N Engl J Med. 1998;338:679-681.
34. Morrish NJ, Stevens LK, Fuller JH, Jarrett RJ, Keen H. Risk factors for macro-vascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia. 1991;34:590-594.
35. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyörälä K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in non-diabetic and non-insulin-dependent diabetic subjects. Stroke. 1996;27:2033-2039.
36. Turner RC, Millns H, Neil HA, et al, for the UKPDS Group. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ. 1998;316:823-828.
37. Wannamethee G, Shaper AG. Physical activity and stroke in British middle aged men. BMJ. 1992;304:597-601.
38. Lehto S, Ronnemaa T, Pyörälä K, Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke. 1996;27:63-68.
39. Toyry JP, Niskanen LK, Lansimies EA, Partanen KPL, Uusitupa MIJ. Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1996;27:1316-1318.
40. Lithner F, Asplund K, Eriksson S, Hagg E, Strand T, Wester PO. Clinical characteristics in diabetic stroke patients. Diabetes Metab. 1988;14:15-19.
41. Morley J, Marinchak R, Rials SJ, Kowey P. Atrial fibrillation, anticoagulation, and stroke. Am J Cardiol. 1996;77:38A-44A.
42. Munschauer FE, Priore RL, Hens M, Castilone A. Thromboembolism prophylaxis in chronic atrial fibrillation: practice patterns in community and tertiary-care hospitals. Stroke. 1997;28:72-76.
43. Antani MR, Beyth RJ, Covinsky KE, et al. Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation. J Gen Intern Med. 1996;11:713-720.
44. Carey PA, More R. Atrial fibrillation and its management. Br J Cardiol. 1997;4: 56-63.
45. Yudkin JS. Factors influencing threshold and choice of treatment for hypertension in NIDDM: cardiovascular factors. Diabetes Care. 1991;14(suppl 4):27-32.
46. Loh E, Sutton MS, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336:251-257.